Published Date: 16 Feb 2023
How is the SARS-CoV-2 mRNA antibody similar to the P.1 gamma strain and other strains?
Read Full NewsPolverino stresses the need for prospective analysis to validate CC16 and mucus plugs as viable biomarkers for COPD status.
In a recently published study, integrating prehospital GFAP measurements with established stroke scales significantly improved the accuracy of large vessel occlusion detection in patients with acute stroke.
Here's some of what is coming soon to NeurologyLive® this week.
Inside MS: A Clinician's Compass, a podcast hosted by neuroimmunologist Lindsay Ross, MD, brings you an exclusive interview with Edith Graham, MD. [LISTEN TIME: 40 minutes]
Sands explains the potential benefits of obefazimod and reviews findings from ABTECT 1 and ABTECT 2 presented at ACG 2025.
In this end-of-year reel, HCPLive has showcased several key highlights from the Skin of Color Savvy podcast in 2025.
This episode of Skin of Color Savvy was filmed on-site at the Skin of Color Society's 'Meeting the Challenge Summit' in Washington, DC.
1.
Lung cancer screening adherence rates decline annually after baseline screening
2.
US Counties Suffered Significantly from a Lack of Psychiatric Care.
3.
Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments
4.
Analysis of projected cancer rates in Canada by 2024.
5.
Tumor characteristics found to differ for melanomas in children, teens and young adults
1.
Managing Acute Respiratory Failure in Hematological Malignancies
2.
Everything You Need to Know About RDW-CV: A Comprehensive Guide
3.
AI and Optical Advances: Evolving Blood Cell Morphology Observation in Hematology
4.
Different Types of Blood Dyscrasias
5.
Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
2.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation